{
    "clinical_study": {
        "@rank": "67232", 
        "acronym": "FROST I", 
        "arm_group": [
            {
                "arm_group_label": "Target Temperature Management of 34\u00b0C", 
                "arm_group_type": "Other", 
                "description": "In hospital target temperature management to achieve core body temperature of 34\u00b0C for 24 hours."
            }, 
            {
                "arm_group_label": "Target Temperature Management of 32\u00b0C", 
                "arm_group_type": "Other", 
                "description": "In hospital target temperature management to achieve core body temperature of 32\u00b0C  for 24 hours."
            }, 
            {
                "arm_group_label": "Target Temperature Management of 33\u00b0C", 
                "arm_group_type": "Other", 
                "description": "In hospital target temperature management to achieve core body temperature of 33\u00b0C  for 24 hours."
            }
        ], 
        "brief_summary": {
            "textblock": "To assess the fraction of subjects surviving with good neurological outcome at 90 days for 3\n      different levels of hypothermia, in comatose survivors from out-of-hospital cardiac arrest."
        }, 
        "brief_title": "Finding the Optimal Cooling tempeRature After Out-of-HoSpiTal Cardiac Arrest", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Out-Of-Hospital Cardiac Arrest.", 
        "condition_browse": {
            "mesh_term": [
                "Heart Arrest", 
                "Out-of-Hospital Cardiac Arrest"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent (obtained from their legal representative)\n\n          -  18 years of age or older and less than 80 years old.\n\n          -  Witnessed OHCA of presumed cardiac cause\n\n          -  Sustained ROSC (when chest compressions have not been required for 20 consecutive\n             minutes and signs of circulation persist)\n\n          -  Initial shockable cardiac rhythm (documented by ECG or AED)\n\n          -  Interval from collapse to advance life support < 20 minutes\n\n          -  Interval from collapse to ROSC < 60 minutes\n\n          -  Lack of meaningful response to verbal commands upon arrival to hospital after\n             suffering non-traumatic cardiac arrest in an out-of-hospital setting\n\n          -  Systolic blood pressure of >90 maintained for a least 30 minutes post-ROSC without\n             pressors, or with a stable dose of pressors\n\n        Exclusion Criteria:\n\n          -  Traumatic cardiac arrest\n\n          -  Toxicological etiology\n\n          -  Known or suspected pregnancy\n\n          -  Do Not Attempt to Resuscitate order in force\n\n          -  Unwitnessed arrest\n\n          -  In-Hospital arrest\n\n          -  Anatomy, previous surgery or disease state contraindicating femoral venous access\n\n          -  Received neuromuscular blocking agents prior to assessing level of consciousness\n             following ROSC\n\n          -  Neurological evaluation insufficient/incomplete after ROSC but prior to\n             randomization.\n\n          -  Body core temperature < 34\u00baC at randomization\n\n          -  Current Inferior Vena Cava (IVC) filter\n\n          -  Known history of acute neurological illness or severe functional disabilities prior\n             to arrest (e.g., seizures, traumatic brain injury, increased intracranial pressures,\n             intra-cerebral hemorrhage, etc).\n\n          -  Known hypersensitivity to hypothermia including a history of Raynaud's disease\n\n          -  Suspected or confirmed acute intracranial bleeding\n\n          -  Suspected or confirmed acute stroke\n\n          -  Terminal illness or life expectancy of less than 3 months prior to arrest\n\n          -  Currently enrolled in another investigational new drug or device trial that has not\n             completed the primary endpoint or that clinically interferes with this Trial's\n             endpoints (For the purpose of this protocol, subjects involved in extended follow-up\n             trials or registries for products that are currently commercially available are not\n             considered enrolled in an investigational trial).\n\n          -  Transferred from a non-participating hospital."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02035839", 
            "org_study_id": "FROST I-Trial"
        }, 
        "intervention": [
            {
                "arm_group_label": "Target Temperature Management of 34\u00b0C", 
                "description": "In hospital target temperature management to achieve core body temperature of 34\u00b0C for 24 hours.", 
                "intervention_name": "Target Temperature Management of 34\u00b0C", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Target Temperature Management of 32\u00b0C", 
                "description": "In hospital target temperature management to achieve core body temperature of 32\u00b0C for 24 hours.", 
                "intervention_name": "Target Temperature Management of 32\u00b0C", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Target Temperature Management of 33\u00b0C", 
                "description": "In hospital target temperature management to achieve core body temperature of 33\u00b0C for 24 hours.", 
                "intervention_name": "Target Temperature Management of 33\u00b0C", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Target Temperature Management", 
            "cooling comatose survivors from out-of- hospital cardiac arrest", 
            "Good neurological outcome at modified Rankin Score (mRS) \u2264 3"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "link": {
            "description": "Pilot trial comparing 2 levels of target temperature. Circulation. 2012;126:2826-2833", 
            "url": "http://circ.ahajournals.org/"
        }, 
        "location": {
            "contact": {
                "email": "e.lopezdesa@terra.com", 
                "last_name": "Prof. Esteban Lopez-de-Sa, M.D", 
                "phone": "+34 91 207 1990"
            }, 
            "facility": {
                "address": {
                    "city": "Madrid", 
                    "country": "Spain", 
                    "state": "Pso. de la castellana", 
                    "zip": "26128046"
                }, 
                "name": "Hospital Universitario La Paz. Planta"
            }, 
            "investigator": {
                "last_name": "Prof. Esteban Lopez-de-Sa, M.D", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multicenter Randomized Trial on the Effectiveness of Different Levels of Cooling in Comatose Survivors of Out-of-hospital Cardiac Arrest.", 
        "overall_contact": {
            "email": "dvillegas@zoll.com", 
            "last_name": "Diana Villegas, M.D., Ph.D.", 
            "phone": "1 (408) 419-2321"
        }, 
        "overall_official": {
            "affiliation": "Hospital Universitario La Paz. Planta", 
            "last_name": "Prof. Esteban Lopez-de-Sa, M.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Fraction of subjects surviving with good neurologic outcome(modified Rankin Score (mRS) \u2264 3) at 90 days after out-of-hospital cardiac arrest.", 
            "safety_issue": "No", 
            "time_frame": "at 90 days after out-of-hospital cardiac arrest"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02035839"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Fraction of subjects with good neurologic outcome (mRS \u2264 3) at discharge after out-of-hospital cardiac arrest", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 7 days after out-of-hospital cardiac arrest"
            }, 
            {
                "measure": "Identify possible covariates influencing survival with good neurological outcome.", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "measure": "To assess safety with each target temperature with regard to bleeding, infection, renal impairment, hypokalemia and arrhythmia.", 
                "safety_issue": "Yes", 
                "time_frame": "72 hours and 7 days"
            }
        ], 
        "source": "ZOLL Circulation, Inc., USA", 
        "sponsors": {
            "collaborator": {
                "agency": "Instituto de Investigaci\u00f3n Hospital Universitario La Paz", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "ZOLL Circulation, Inc., USA", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}